Related references
Note: Only part of the references are listed.Vaccine Efficacy of Self-Assembled Multimeric Protein Scaffold Particles Displaying the Glycoprotein Gn Head Domain of Rift Valley Fever Virus
Paul J. Wichgers Schreur et al.
VACCINES (2021)
A comparative genome analysis of Rift Valley Fever virus isolates from foci of the disease outbreak in South Africa in 2008-2010
Moabi R. Maluleke et al.
PLOS NEGLECTED TROPICAL DISEASES (2019)
First Laboratory-Confirmed Outbreak of Human and Animal Rift Valley Fever Virus in Uganda in 48 Years
Trevor R. Shoemaker et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2019)
First occurrence of Rift Valley fever outbreak in Niger, 2016
Adamou Lagare et al.
VETERINARY MEDICINE AND SCIENCE (2019)
Rift Valley Fever Reemergence after 7 Years of Quiescence, South Africa, May 2018
Petrus Jansen van Vuren et al.
EMERGING INFECTIOUS DISEASES (2019)
Rift Valley Fever Virus-How and Where Virus Is Maintained During Inter-epidemic Periods
M. Kariuki Njenga et al.
CURRENT CLINICAL MICROBIOLOGY REPORTS (2019)
Evaluation of Fluorescence Microsphere Immunoassay for Detection of Antibodies to Rift Valley Fever Virus Nucleocapsid Protein and Glycoproteins
I. K. Ragan et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2018)
Advanced surveillance and preparedness to meet a new era of invasive vectors and emerging vector-borne diseases
Rebekah C. Kading et al.
PLOS NEGLECTED TROPICAL DISEASES (2018)
Current Status of Rift Valley Fever Vaccine Development
Bonto Faburay et al.
VACCINES (2017)
Rift Valley Fever: An Emerging Mosquito-Borne Disease
Kenneth J. Linthicum et al.
ANNUAL REVIEW OF ENTOMOLOGY, VOL 61 (2016)
Rift Valley fever MP-12 vaccine Phase 2 clinical trial: Safety, immunogenicity, and genetic characterization of virus isolates
Phillip R. Pittman et al.
VACCINE (2016)
Safety and immunogenicity of a mutagenized, live attenuated Rift Valley fever vaccine, MP-12, in a Phase 1 dose escalation and route comparison study in humans
Phillip R. Pittman et al.
VACCINE (2016)
Multiplex Detection of IgG and IgM to Rift Valley Fever Virus Nucleoprotein, Nonstructural Proteins, and Glycoprotein in Ovine and Bovine
Mohammad M. Hossain et al.
VECTOR-BORNE AND ZOONOTIC DISEASES (2016)
Experimental Infection of Calves by Two Genetically-Distinct Strains of Rift Valley Fever Virus
William C. Wilson et al.
VIRUSES-BASEL (2016)
A Recombinant Rift Valley Fever Virus Glycoprotein Subunit Vaccine Confers Full Protection against Rift Valley Fever Challenge in Sheep
Bonto Faburay et al.
SCIENTIFIC REPORTS (2016)
Rift Valley Fever Vaccine Virus Clone 13 Is Able to Cross the Ovine Placental Barrier Associated with Foetal Infections, Malformations, and Stillbirths
Birgit Makoschey et al.
PLOS NEGLECTED TROPICAL DISEASES (2016)
Chimpanzee Adenovirus Vaccine Provides Multispecies Protection against Rift Valley Fever
George M. Warimwe et al.
SCIENTIFIC REPORTS (2016)
Major emerging vector-borne zoonotic diseases of public health importance in Canada
Manisha A. Kulkarni et al.
EMERGING MICROBES & INFECTIONS (2015)
Potential for North American Mosquitoes (Diptera: Culicidae) to Transmit Rift Valley Fever Virus
Michael J. Turell et al.
JOURNAL OF MEDICAL ENTOMOLOGY (2015)
A Glycoprotein Subunit Vaccine Elicits a Strong Rift Valley Fever Virus Neutralizing Antibody Response in Sheep
Bonto Faburay et al.
VECTOR-BORNE AND ZOONOTIC DISEASES (2014)
Relevance of Rift Valley fever to public health in the European Union
V. Chevalier
CLINICAL MICROBIOLOGY AND INFECTION (2013)
Development of a Rift Valley fever real-time RT-PCR assay that can detect all three genome segments
William C. Wilson et al.
JOURNAL OF VIROLOGICAL METHODS (2013)
Rift Valley Fever Virus Structural and Nonstructural Proteins: Recombinant Protein Expression and Immunoreactivity Against Antisera from Sheep
Bonto Faburay et al.
VECTOR-BORNE AND ZOONOTIC DISEASES (2013)
Socio-economic impact of Rift Valley fever to pastoralists and agro pastoralists in Arusha, Manyara and Morogoro regions in Tanzania
Augustino A. Chengula et al.
SPRINGERPLUS (2013)
Molecular biology and genetic diversity of Rift Valley fever virus
Tetsuro Ikegami
ANTIVIRAL RESEARCH (2012)
The Nonstructural Protein NSs Induces a Variable Antibody Response in Domestic Ruminants Naturally Infected with Rift Valley Fever Virus
Jose-Carlos Fernandez et al.
CLINICAL AND VACCINE IMMUNOLOGY (2012)
Efficacy of three candidate Rift Valley fever vaccines in sheep
J. Kortekaas et al.
VACCINE (2012)
Safety and efficacy of Rift Valley fever Smithburn and Clone 13 vaccines in calves
Beate von Teichman et al.
VACCINE (2011)
Evaluation of the efficacy and safety of the Rift Valley Fever Clone 13 vaccine in sheep
Baptiste Dungu et al.
VACCINE (2010)
Rift Valley fever virus immunity provided by a paramyxovirus vaccine vector
J. Kortekaas et al.
VACCINE (2010)
Recombinant nucleocapsid-based ELISA for detection of IgG antibody to Rift Valley fever virus in African buffalo
Janusz T. Paweska et al.
VETERINARY MICROBIOLOGY (2008)
Immunogenicity of combination DNA vaccines for Rift Valley fever virus, tick-borne encephalitis virus, Hantaan virus, and Crimean Congo hemorrhagic fever virus
Kristin Spik et al.
VACCINE (2006)
Epidemic rift valley fever in Saudi Arabia: A clinical study of severe illness in humans
M Al-Hazmi et al.
CLINICAL INFECTIOUS DISEASES (2003)
Isolation and genetic characterization of Rift Valley Fever virus from Aedes vexans arabiensis, Kingdom of Saudi Arabia
BR Miller et al.
EMERGING INFECTIOUS DISEASES (2002)
Share Paper
